Prenetics Global Ltd | 7.25% Series E Cumulative Redeemable Preferred Shares (PRE.PRE)
Prospectus excerpt: PartnerRe Ltd. is offering 13,000,000 shares of its 7.25% Series E Cumulative Redeemable Preferred Shares, which we refer to in this prospectus supplement as the ŮSeries E preferred shares. The Series E preferred shares will not be redeemable before June 1, 2016, except in specified circumstances relating to certain tax events. Beginning on June 1, 2016, PartnerRe Ltd. may redeem the Series E preferred shares, in whole at any time or in part from time to time, at $25.00 per share plus accumulated and unpaid dividends without interest. Dividends on the Series E preferred shares are cumulative from the date of issuance and are payable quarterly in arrears on the first day of March, June, September and December, commencing September 1, 2011. The Series E preferred shares will have no stated maturity and are not subject to any sinking fund or mandatory redemption and are not convertible into any other securities.
Full Prospectus PDF », Secondary Prospectus PDF », PRE Page »
|
Prenetics Global is a holding company. Through its subsidiary, Prenetics Holding Company Limited, Co. is a diagnostics and genetics testing products and services provider. Co.'s pipeline products and services include: ColoClear, which is a non-invasive fecal immunochemical test and multi-target stool-based DNA testing colorectal cancer screening test; Circle SnapShot, which is an off-the-shelf at-home blood test where individuals can get digital access to their own health information; and Circle One, F1x and Fem, which develop to provide its customers personalized nutrition, hair loss and sexual health products tailored to each of its customer's genetic variation and biology. Preferreds: PRE.PRC, PRE.PRD, PRE.PRE, PRE.PRF, PRE.PRG, PRE.PRH, PRE.PRI, PRE.PRJ Open the PRE Information Page » |
|
|
Free Email Alerts: Get Dividend Alerts Get SEC Filing Alerts |
|